Skip to content
Home/Companies/Biotech/Rewind Therapeutics

Rewind Therapeutics

Biotech·Belgium·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Rewind Therapeutics?

Rewind Therapeutics is currently owned by Sunstone Life Science Ventures through Sunstone Life Science Ventures V (2021 vintage), since 2023. Across its history, Rewind Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-07-03

Sunstone Life Science Ventures
Most recent investor
Sunstone Life Science Ventures
Sunstone Life Science Ventures V · 2021 · VC
2 ownership periods · full history below

Key facts

HQBelgium
SectorBiotech
StatusActive

Ownership history

2 ownership periods · co-invest detected

Co-invest · 2 holders · 2017 · present
Boehringer Ingelheim Venture Fund
2017 · present(9yr) · Boehringer Ingelheim Venture Fund · 2010 · Evergreen
Sunstone Life Science Ventures
2023 · present(3yr) · Sunstone Life Science Ventures V · 2021 · VC
Track Rewind Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Rewind Therapeutics?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Rewind Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue